JOGO Health, a medtech company focused on the treatment of chronic pain and neuromuscular disorders, has closed over $5.5 million in a funding round led by Hourglass Ventures. Due to high demand from investors, JOGO Health is now extending the opportunity to the public through a Regulation CF community investment round on Wefunder. This allows retail investors to participate alongside established firms like Mayo Clinic Ventures, the venture arm of the Mayo Clinic.

JOGO Health’s technology uses wearable devices and an app to harness the brain’s natural neuroplasticity, providing non-invasive, drug-free relief for conditions such as chronic lower back pain, stroke recovery, migraines, and incontinence. The technology has been cleared by the FDA and is reimbursed by Medicare and commercial insurance. Supported by 18 patent claims across various neuromuscular conditions, JOGO Health has treated over 25,000 patients through partnerships with more than 50 hospitals, including Mayo Clinic, Mount Sinai Hospital, and Brigham and Women’s Hospital.

The leadership at JOGO Health includes experienced healthcare entrepreneurs from institutions such as Columbia University, Harvard University, Yale University, AT&T, Johnson & Johnson, and Astrazeneca. Co-Founder and CEO Sanjai Murali guided the company from inception to FDA market authorization. President and Co-Founder Siva Nadarajah previously led an AI healthcare startup to a successful exit, providing a 10x return to investors.

“The conviction of our investors is phenomenal,” said Nadarajah. “This round will enable us to meet growing demand.”

Murali also emphasized the inclusive vision behind JOGO Health’s latest move: “We believe healthcare is too important to be controlled by a few. JOGO is founded on the vision of ‘by the world, for the world,’ and opening our investment round to retail investors on Wefunder is a crucial step towards realizing this vision.”

The capital raised will support JOGO Health’s commercial launch, with the aim of establishing its technology as a primary treatment for chronic pain and other neuromuscular disorders, which affect 1 in 5 people globally, according to the company. The community investment round on Wefunder is open to everyone, with a minimum investment of $100.

Show CommentsClose Comments

Leave a comment